Stacey E Jolly

Summary

Affiliation: Cleveland Clinic Foundation
Country: USA

Publications

  1. pmc Uric acid, hypertension, and chronic kidney disease among Alaska Eskimos: the Genetics of Coronary Artery Disease in Alaska Natives (GOCADAN) study
    Stacey E Jolly
    General Internal Medicine, Cleveland Clinic Medicine Institute, 9500 Euclid Avenue, Cleveland, OH 44195, USA
    J Clin Hypertens (Greenwich) 14:71-7. 2012
  2. pmc Racial and ethnic differences in mortality among individuals with chronic kidney disease: results from the Kidney Early Evaluation Program (KEEP)
    Stacey E Jolly
    Cleveland Clinic Medicine Institute, 9500 Euclid Avenue G10, Cleveland, Ohio 44195, USA
    Clin J Am Soc Nephrol 6:1858-65. 2011
  3. pmc Cardiac procedures among American Indians and Alaska Natives compared to non-Hispanic whites hospitalized with ischemic heart disease in California
    Stacey Jolly
    Department of Medicine, Division of General Internal Medicine, University of California San Francisco, San Francisco General Hospital, San Francisco, CA, USA
    J Gen Intern Med 25:430-4. 2010
  4. pmc Albuminuria among Alaska Natives--findings from the Genetics of Coronary Artery Disease in Alaska Natives (GOCADAN) study
    Stacey E Jolly
    Medicine Department, Division of General Internal Medicine, University of California San Francisco, San Francisco, CA, USA
    Nephron Clin Pract 115:c107-13. 2010
  5. doi request reprint Higher cardiovascular disease prevalence and mortality among younger blacks compared to whites
    Stacey Jolly
    Department of Medicine, University of California, San Francisco, CA, USA
    Am J Med 123:811-8. 2010
  6. ncbi request reprint Sex-specific associations of nutrition with hypertension and systolic blood pressure in Alaska Natives findings from the GOCADAN study
    Stacey E Jolly
    Cleveland Clinic Medicine Institute, Cleveland, OH, USA
    Int J Circumpolar Health 70:254-65. 2011
  7. pmc Serum bicarbonate and mortality in stage 3 and stage 4 chronic kidney disease
    Sankar D Navaneethan
    Department of Nephrology, Hypertension, Glickman Urological and Kidney Institute, and Cleveland Clinic Lerner College of Medicine of CWRU, Cleveland, OH 44195, USA
    Clin J Am Soc Nephrol 6:2395-402. 2011
  8. pmc Racial and ethnic differences in albuminuria in individuals with estimated GFR greater than 60 mL/min/1.73 m(2): results from the Kidney Early Evaluation Program (KEEP)
    Stacey E Jolly
    General Internal Medicine, Cleveland Clinic Medicine Institute, Cleveland, OH
    Am J Kidney Dis 55:S15-22. 2010
  9. pmc Metabolic syndrome, ESRD, and death in CKD
    Sankar D Navaneethan
    Department of Nephrology and Hypertension, Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, Ohio 44195, USA
    Clin J Am Soc Nephrol 8:945-52. 2013
  10. pmc Low 25-hydroxyvitamin D levels and mortality in non-dialysis-dependent CKD
    Sankar D Navaneethan
    Department of Nephrology and Hypertension, Glickman Urological and Kidney Institute, Cleveland, OH 44195, USA
    Am J Kidney Dis 58:536-43. 2011

Detail Information

Publications17

  1. pmc Uric acid, hypertension, and chronic kidney disease among Alaska Eskimos: the Genetics of Coronary Artery Disease in Alaska Natives (GOCADAN) study
    Stacey E Jolly
    General Internal Medicine, Cleveland Clinic Medicine Institute, 9500 Euclid Avenue, Cleveland, OH 44195, USA
    J Clin Hypertens (Greenwich) 14:71-7. 2012
    ..56), respectively). Twenty-one percent (n=230) had prevalent HTN and UA was independently associated with prevalent HTN (adjusted OR, 1.2; 95% CI, 1.1-1.5). UA is independently associated with prevalent CKD and HTN in this population...
  2. pmc Racial and ethnic differences in mortality among individuals with chronic kidney disease: results from the Kidney Early Evaluation Program (KEEP)
    Stacey E Jolly
    Cleveland Clinic Medicine Institute, 9500 Euclid Avenue G10, Cleveland, Ohio 44195, USA
    Clin J Am Soc Nephrol 6:1858-65. 2011
    ..Chronic kidney disease (CKD) is prevalent in minority populations and racial/ethnic differences in survival are incompletely understood...
  3. pmc Cardiac procedures among American Indians and Alaska Natives compared to non-Hispanic whites hospitalized with ischemic heart disease in California
    Stacey Jolly
    Department of Medicine, Division of General Internal Medicine, University of California San Francisco, San Francisco General Hospital, San Francisco, CA, USA
    J Gen Intern Med 25:430-4. 2010
    ..American Indians/Alaska Natives (AIAN) experience a high burden of cardiovascular disease with rates for fatal and nonfatal heart disease approximately twofold higher than the U.S. population...
  4. pmc Albuminuria among Alaska Natives--findings from the Genetics of Coronary Artery Disease in Alaska Natives (GOCADAN) study
    Stacey E Jolly
    Medicine Department, Division of General Internal Medicine, University of California San Francisco, San Francisco, CA, USA
    Nephron Clin Pract 115:c107-13. 2010
    ..The prevalence and associated risk factors for albuminuria and low-grade albuminuria in Alaska Natives is not known...
  5. doi request reprint Higher cardiovascular disease prevalence and mortality among younger blacks compared to whites
    Stacey Jolly
    Department of Medicine, University of California, San Francisco, CA, USA
    Am J Med 123:811-8. 2010
    ..Blacks have higher rates of cardiovascular disease than whites. The age at which these differential rates emerge has not been fully examined...
  6. ncbi request reprint Sex-specific associations of nutrition with hypertension and systolic blood pressure in Alaska Natives findings from the GOCADAN study
    Stacey E Jolly
    Cleveland Clinic Medicine Institute, Cleveland, OH, USA
    Int J Circumpolar Health 70:254-65. 2011
    ..To examine sex-specific associations of nutritional factors with prevalent hypertension (HTN) and systolic blood pressure (SBP) in Alaska Natives. Diet is known to affect SBP, a major risk factor for cardiovascular disease...
  7. pmc Serum bicarbonate and mortality in stage 3 and stage 4 chronic kidney disease
    Sankar D Navaneethan
    Department of Nephrology, Hypertension, Glickman Urological and Kidney Institute, and Cleveland Clinic Lerner College of Medicine of CWRU, Cleveland, OH 44195, USA
    Clin J Am Soc Nephrol 6:2395-402. 2011
    ..We studied the associations of both low and high serum bicarbonate levels with all-cause mortality among stage 3 and 4 chronic kidney disease (CKD) patients...
  8. pmc Racial and ethnic differences in albuminuria in individuals with estimated GFR greater than 60 mL/min/1.73 m(2): results from the Kidney Early Evaluation Program (KEEP)
    Stacey E Jolly
    General Internal Medicine, Cleveland Clinic Medicine Institute, Cleveland, OH
    Am J Kidney Dis 55:S15-22. 2010
    ..We sought to estimate independent associations of race/ethnicity with albuminuria to determine whether observed differences were attributable to known kidney disease risk factors...
  9. pmc Metabolic syndrome, ESRD, and death in CKD
    Sankar D Navaneethan
    Department of Nephrology and Hypertension, Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, Ohio 44195, USA
    Clin J Am Soc Nephrol 8:945-52. 2013
    ..This study examined the associations between metabolic syndrome and its components with ESRD and death among those patients with stages 3 and 4 CKD (estimated GFR=15-59 ml/min per 1.73 m(2))...
  10. pmc Low 25-hydroxyvitamin D levels and mortality in non-dialysis-dependent CKD
    Sankar D Navaneethan
    Department of Nephrology and Hypertension, Glickman Urological and Kidney Institute, Cleveland, OH 44195, USA
    Am J Kidney Dis 58:536-43. 2011
    ..Low 25-hydroxyvitamin D (25[OH]D) levels are common in patients with non-dialysis-dependent chronic kidney disease (CKD). The associations between low 25(OH)D levels and mortality in non-dialysis-dependent patients with CKD are unclear...
  11. pmc Risk factors for chronic kidney disease among American Indians and Alaska Natives--findings from the Kidney Early Evaluation Program
    Stacey E Jolly
    General Internal Medicine Division, University of California San Francisco, San Francisco, CA 94143, USA
    Am J Nephrol 29:440-6. 2009
    ..Less is known about chronic kidney disease (CKD) among AIAN and whether risk factors differ for low estimated glomerular filtration rate (eGFR) versus albuminuria with a normal eGFR...
  12. pmc Implications of the CKD-EPI GFR estimation equation in clinical practice
    Jesse D Schold
    Quantitative Health Sciences, Cleveland Clinic, Cleveland, Ohio, USA
    Clin J Am Soc Nephrol 6:497-504. 2011
    ..CKD-EPI demonstrated superior performance compared with the existing MDRD equation but has not been applied to a healthcare system...
  13. pmc Serum triglycerides and risk for death in Stage 3 and Stage 4 chronic kidney disease
    Sankar D Navaneethan
    Department of Nephrology and Hypertension, Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, OH, USA
    Nephrol Dial Transplant 27:3228-34. 2012
    ..The associations between serum triglyceride and all-cause mortality among patients with chronic kidney disease (CKD) are unclear...
  14. ncbi request reprint Chronic kidney disease in an electronic health record problem list: quality of care, ESRD, and mortality
    Stacey E Jolly
    Department of General Internal Medicine, Medicine Institute, Cleveland Clinic, Cleveland, Ohio, USA
    Am J Nephrol 39:288-96. 2014
    ..Whether chronic kidney disease (CKD) recognition in an electronic health record (EHR) problem list improves processes of care or clinical outcomes of end-stage renal disease (ESRD) and death is unclear...
  15. pmc Electronic health records: a new tool to combat chronic kidney disease?
    Sankar D Navaneethan
    Department of Neprology and Hypertension, Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, OH 44195, USA
    Clin Nephrol 79:175-83. 2013
    ..Thus, future studies should explore the optimal methods of using EHRs to improve CKD care and research at the individual patient level, health system and population levels...
  16. pmc Blood pressure components and end-stage renal disease in persons with chronic kidney disease: the Kidney Early Evaluation Program (KEEP)
    Carmen A Peralta
    Department of Medicine, San Francisco VA Medical Center, San Francisco, California, USA
    Arch Intern Med 172:41-7. 2012
    ..Treatment of hypertension is difficult in chronic kidney disease (CKD), and blood pressure goals remain controversial. The association between each blood pressure component and end-stage renal disease (ESRD) risk is less well known...
  17. pmc Development and validation of an electronic health record-based chronic kidney disease registry
    Sankar D Navaneethan
    Department of Nephrology and Hypertension, Glickman Urological and Kidney Institute, 9500 Euclid Avenue, Q7, Cleveland Clinic, Cleveland, OH 44195, USA
    Clin J Am Soc Nephrol 6:40-9. 2011
    ..We developed an electronic health record (EHR)-based CKD registry at the Cleveland Clinic and validated comorbid conditions...